The invention relates to a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta<;sub>;2<;/sub>;-adrenoceptor agonist, and, optionally, an inhaled corticosteroid, and to a process for preparation thereof.